Premium
Simultaneous determination of quinolone antibacterials in bovine milk by liquid chromatography–mass spectrometry
Author(s) -
ZafraGómez Alberto,
Garballo Antonio,
Ballesteros Oscar,
Navalón Alberto,
GarcíaAyuso Luís E.
Publication year - 2008
Publication title -
biomedical chromatography
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.4
H-Index - 65
eISSN - 1099-0801
pISSN - 0269-3879
DOI - 10.1002/bmc.1041
Subject(s) - chemistry , chromatography , danofloxacin , flumequine , formic acid , liquid chromatography–mass spectrometry , enrofloxacin , mass spectrometry , oxolinic acid , residue (chemistry) , ciprofloxacin , nalidixic acid , antibiotics , biochemistry
A new liquid chromatography–mass spectrometry (LC–MS) method has been developed and validated for the simultaneous determination of eight quinolone antibacterials for veterinary use in processed bovine milk samples. The quinolones studied included marbofloxacin, ciprofloxacin, danofloxacin, enrofloxacin, sarafloxacin, difloxacin, oxolinic acid and flumequine. Also, a new sample‐treatment procedure was used for extraction and preconcentration of these compounds. It involved defatting by centrifugation, protein precipitation by adding a mixture of glacial acetic acid–acetonitrile and removing acetonitrile with dichloromethane; finally, the acidified aqueous layer was evaporated to dryness in a speed vac system, resuspended in the mobile phase and filtered prior to LC injection. The mobile phase was composed of a formic acid aqueous solution 0.1% (v/v) and acetonitrile, with an initial composition of water–acetonitrile 95: 5 (v/v) and using linear gradient elution. Norfloxacin was used as internal standard. The limits of quantification found (2–7 ng g −1 ) were in all cases lower than the maximum residue limits tolerated by the European Union for these compounds in milk. Copyright © 2008 John Wiley & Sons, Ltd.